KRAS and cancer: Activation of Wnt/β-catenin signaling can work in conjunction with other oncogenic pathways such as KRAS in lung epithelial cells to produce a more aggressive cancer phenotype by forcing an embryonic distal progenitor phenotype and reducing E-cadherin expression (Pacheco-Pinedo et al., 2011; Hung et al., 2020).